GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders. . . . → Read More: Oxford, GSK Partner on New Tech for Neuro Diseases
|
|||||
       
  |
A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics. . . . → Read More: $180M Venture Fund Backing Age-Related Disease Start-Ups 
A clinical trial completed enrollment of lung cancer patients testing a device sending an electric field into their tumors to disrupt cancer cell proliferation. . . . → Read More: Trial Advances Test of Electronic Cancer Treatment 
A start-up enterprise creating milk and dairy products with proteins derived from engineered microorganisms is raising $13 million in seed funds. . . . → Read More: Synthetic Bio Milk Company Gains $13M in Seed Funds  One comment - (Comments are closed)  Finance, New products  agriculture, biotechnology, engineering, entrepreneurs, equity, genomics, investment, Israel, life sciences, mathematics, physical sciences, university, venture capital 
Results from tests with lab mice show an experimental targeted cancer therapy invoking the immune system shrinks tumors and prevents their recurrence. . . . → Read More: Targeted Immunotherapy Shown to Shrink, Stop Tumors 2 comments - (Comments are closed) New products biomedical, biotechnology, cancer, entrepreneurs, life sciences, pharmaceuticals, preclinical, university 
A clinical trial shows a drug derived from the hallucinogenic compound psilocybin reduces symptoms of depression, when part of a therapy program. . . . → Read More: Trial Shows Psilocybin Drug Helps Reduce Depression Comments are closed New products biomedical, clinical trials, life sciences, pharmaceuticals, psychiatric, university 
Biomedical engineers found a chip device with intestinal tissue can simulate coronavirus infections and symptoms in the gut, and test possible treatments. . . . → Read More: Chip Device Simulates Coronavirus Gut Symptoms Comments are closed New products biomedical, Covid-19, engineering, life sciences, medical device, physical sciences, preclinical, university 
A developer of off-the-shelf genetically engineered platelet cells to treat a range of diseases is raising $75.5 million in its second venture round. . . . → Read More: Cell Therapy Biotech Raises $75.5M in Venture Funds Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, preclinical, stem cells, university, venture capital 
A company designing engineered proteins to work better than natural chemistries as treatments for disease is raising $25 million in its first venture round. . . . → Read More: Synthetic Protein Company Gains $25M in New Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, physical sciences, university, venture capital 
Lab tests show an ingestible hydrogel designed to encourage weight loss by acting like raw vegetables helps protect and regulate intestinal tissue. . . . → Read More: Hydrogel Obesity Capsule Shown to Protect Gut Tissue Comments are closed New products biomedical, biotechnology, Europe, life sciences, materials science, pharmaceuticals, physical sciences, preclinical, university |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
